Table 2 Clinical characteristics. Statistical analysis was performed using Wilcoxon rank-sum test and Fisher’s exact test for continuous and categorical variables, respectively. Cases with X stage in T, N, and M or NA were excluded in the statistical analysis
Characteristics | High risk group (N = 53) | Low risk group (N = 673) | p-value | |
|---|---|---|---|---|
Diagnosis age (Median) | 59 | 58 | 0.9565 | |
Survival time (Median) | 20.4 | 28.8 | 0.0353 | |
Vital status | Living | 43 | 617 | 0.0211 |
Deceased | 10 | 56 | ||
Race | Asian | 3 | 34 | 0.0527 |
African American | 16 | 123 | ||
White | 31 | 504 | ||
Other/NA | 3 | 12 | ||
PAM50 subtype | Luminal A | 10 | 376 | 7.7E−7 |
Luminal B | 19 | 121 | ||
HER2 | 6 | 37 | ||
Basal | 17 | 109 | ||
Normal-like | 1 | 30 | ||
ER status | Negative | 14 | 143 | 0.3842 |
Positive | 36 | 491 | ||
NA | 3 | 39 | ||
PR status | Negative | 23 | 197 | 0.0267 |
Positive | 26 | 435 | ||
NA | 4 | 41 | ||
HER2 status | Equivocal | 9 | 118 | 0.0316 |
Indeterminate | 1 | 9 | ||
Negative | 20 | 352 | ||
Positive | 12 | 70 | ||
NA | 11 | 124 | ||
T | T1 | 4 | 178 | 0.0008 |
T2 | 42 | 376 | ||
T3 | 4 | 98 | ||
T4 | 3 | 19 | ||
TX | 0 | 2 | ||
N | N0 | 19 | 302 | 0.5169 |
N1 | 23 | 230 | ||
N2 | 6 | 86 | ||
N3 | 4 | 47 | ||
NX | 1 | 8 | ||
M | cM0 | 0 | 3 | 0.5529 |
M0 | 34 | 542 | ||
M1 | 1 | 9 | ||
MX | 18 | 119 | ||
Stage | I | 0 | 111 | 0.0011 |
II | 36 | 374 | ||
III | 15 | 172 | ||
IV | 1 | 7 | ||
Other/NA | 1 | 9 | ||
